Financials Caregen Co., Ltd.

Equities

A214370

KR7214370009

Pharmaceuticals

End-of-day quote Korea S.E. 23:00:00 09/05/2024 BST 5-day change 1st Jan Change
21,400 KRW +0.23% Intraday chart for Caregen Co., Ltd. -3.60% -22.18%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 725,681 761,628 703,085 652,094 1,347,135 1,351,191
Enterprise Value (EV) 1 568,991 594,231 575,452 515,826 1,206,656 1,218,468
P/E ratio 44 x 27.2 x 22.5 x 25.8 x 98.7 x 33.8 x
Yield 1.69% 3.66% 2.79% 3.46% 1.97% -
Capitalization / Revenue 14.2 x 11.8 x 11.7 x 11 x 19.5 x 17.1 x
EV / Revenue 11.1 x 9.18 x 9.54 x 8.73 x 17.5 x 15.4 x
EV / EBITDA 26.2 x 15.9 x 16.9 x 17.1 x 32.6 x 26.9 x
EV / FCF 43.4 x 10 x -81.4 x 26.5 x 72.4 x 200 x
FCF Yield 2.31% 9.96% -1.23% 3.77% 1.38% 0.5%
Price to Book 3.52 x 3.51 x 3.43 x 3.11 x 6.24 x 5.94 x
Nbr of stocks (in thousands) 51,176 49,780 49,030 49,030 49,130 49,134
Reference price 2 14,180 15,300 14,340 13,300 27,420 27,500
Announcement Date 18/03/19 06/04/20 19/03/21 18/03/22 14/03/23 11/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 51,211 64,699 60,295 59,088 69,098 79,210
EBITDA 1 21,703 37,445 34,062 30,145 37,053 45,342
EBIT 1 19,744 35,375 31,978 28,109 33,603 40,360
Operating Margin 38.55% 54.68% 53.04% 47.57% 48.63% 50.95%
Earnings before Tax (EBT) 1 22,486 38,921 36,084 33,581 34,457 49,572
Net income 1 16,491 28,070 31,478 25,318 27,267 39,930
Net margin 32.2% 43.39% 52.21% 42.85% 39.46% 50.41%
EPS 2 322.5 562.7 638.6 516.4 277.8 813.0
Free Cash Flow 1 13,123 59,179 -7,069 19,460 16,675 6,080
FCF margin 25.63% 91.47% -11.72% 32.93% 24.13% 7.68%
FCF Conversion (EBITDA) 60.47% 158.04% - 64.56% 45% 13.41%
FCF Conversion (Net income) 79.58% 210.83% - 76.86% 61.16% 15.23%
Dividend per Share 2 240.0 560.0 400.0 460.0 540.0 -
Announcement Date 18/03/19 06/04/20 19/03/21 18/03/22 14/03/23 11/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales 1 24.67 18.38 18.72 17.44
EBITDA - - - -
EBIT 1 12.52 7.636 9.875 10.34
Operating Margin 50.77% 41.54% 52.76% 59.3%
Earnings before Tax (EBT) - - - -
Net income 1 - 7.439 9.8 8.544
Net margin - 40.47% 52.36% 48.99%
EPS - - - -
Dividend per Share - - - -
Announcement Date 04/05/23 09/08/23 10/11/23 05/02/24
1KRW in Billions
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 156,690 167,398 127,633 136,268 140,479 132,724
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 13,123 59,179 -7,069 19,460 16,675 6,080
ROE (net income / shareholders' equity) 7.83% 13.3% 14.9% 12.1% 12.8% 18%
ROA (Net income/ Total Assets) 5.6% 9.81% 8.91% 7.93% 9.11% 10.5%
Assets 1 294,510 286,155 353,123 319,449 299,157 380,974
Book Value Per Share 2 4,032 4,359 4,184 4,277 4,396 4,626
Cash Flow per Share 2 344.0 436.0 326.0 454.0 105.0 642.0
Capex 1 2,276 6,159 21,080 3,888 1,544 8,155
Capex / Sales 4.44% 9.52% 34.96% 6.58% 2.24% 10.3%
Announcement Date 18/03/19 06/04/20 19/03/21 18/03/22 14/03/23 11/03/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A214370 Stock
  4. Financials Caregen Co., Ltd.